STAT

OCTOBER 27, 2022

Amid sporadic shortages of a drug that is essential in preparing patients for lifesaving, cancer-fighting treatments, one manufacturer has returned to the market — but is selling its medicine for 10 to 20 times the prices offered by the only other companies with available supplies.

Dosage 102

Dosage 102

European Pharmaceutical Review

MAY 22, 2023

A review by Swedish researchers has identified the benefits of smart contracts on blockchain platforms in the pharmaceutical supply chain and its role in combating counterfeit drugs. These can lead to inventory shortages, the paper noted. For instance, these drugs must be equipped with real-time insights.

90

90

pharmaphorum

NOVEMBER 27, 2022

Incidents such as the hormone replacement therapy drug shortage in early 2022 have shown the damaging impact supply chain issues can have on people who depend on these drugs. Mix ups in hand-offs are another large disruptor, especially when drugs have specific shipping requirements. Automation can be such a solution.

Communication 105

Communication Pharmaceutical Companies Pharmaceutical Companies Packaging 105

The Checkup by Singlecare

MARCH 7, 2024

Ozempic (semaglutide) is a weekly injectable drug that lowers blood sugar levels. It was approved by the Food and Drug Administration (FDA) in 2017 for treating Type 2 diabetes. Ozempic cost Unfortunately, like many new drugs, Ozempic comes with a hefty price tag. Ozempic cost comparison for 0.25

Health and Personal Care Stores 52

Health and Personal Care Stores Insurance Packaging Insurance Coverage 52

Viseven

SEPTEMBER 14, 2023

The procurement cycle presupposes all decisions related to selecting suppliers and monitoring drug delivery and distribution. It typically falls into the following steps: Reviewing drug selections. Determining drug quantities. Receiving and checking drugs. Aligning needs with the budget. Selecting a procurement method.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Pharmacy Procurement 52

Pharmaceutical Technology

NOVEMBER 30, 2022

In what’s being called a “medical bypass”, new anti-obesity drugs are almost matching efficacy rates in weight loss that have previously only been seen with weight loss surgeries. The drug was approved to treat type 2 diabetes mellitus in May. The drug was approved to treat type 2 diabetes mellitus in May. million in Q3.

Insurance 105

Insurance Labelling Communication FDA 105

Pharmaceutical Technology

NOVEMBER 30, 2022

In what’s being called a “medical bypass”, new anti-obesity drugs are almost matching efficacy rates in weight loss that have previously only been seen with weight loss surgeries. The drug was approved to treat type 2 diabetes mellitus in May. The drug was approved to treat type 2 diabetes mellitus in May. million in Q3.

Insurance 98

Insurance Labelling Communication FDA 98